Antibody–Drug Conjugates for Cancer Therapy
Umbreen Hafeez(La Trobe University), Andrew M. Scott(Olivia Newton-John Cancer Wellness & Research Centre)
Cited by 377
Related Papers
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
|Proceedings of the National Academy of Sciences|2004|440
Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor
|Journal of Biological Chemistry|2004|145
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
|Gene Therapy|2010|118
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
|Molecular Cancer Therapeutics|2018|52